Skip to content

A clinical study to compare the effects of two medicines, Kokilaksham Kshayam and Vasadi Kshayam in patients of joint pains with high blood uric acid levels

A Randomized Controlled Clinical Study to evaluate the comparative efficacy of Kokilaksham Kshayam and Vasadi Kshayam in the management of Vatarakta wsr to Hyperuricemia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039261
Enrollment
100
Registered
2022-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M100- Idiopathic gout

Interventions

None listed

Sponsors

Dr Shivali Arora
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with signs and symptoms of Vatarakta. 2 Patients with hyperuricemia (S. Uric Acid >7mg/dl in males and >6mg/dl in females) 3 Patients willing to participate

Exclusion criteria

Exclusion criteria: 1 Patients below 16years and above 70 yrs of age. 2 Patients having other associated arthropathies. 3 Patients taking uricosuric/ xanthine oxidase inhibitor drugs. 4 patients with S.Uric Acid >10mg/dl. 5 Patients not willing for trial. 6 Patients suffering from chronic disorders like anaemia, diabetes, asthma, cardiac, hepatic and renal diseases. 7 Pregnancy and lactating mothers. 8 Already known Hypersensitivity to interventional drug.

Design outcomes

Primary

MeasureTime frame
1. Decrease in S.Uric acid levels. 2. Improvement in symptoms of vatarakta namely sandhishula,sparshasahishnuta, daha, toda, ratavarnata, shotha.Timepoint: Baseline, 15days, 30days,45days, 60days

Secondary

MeasureTime frame
Growing feeling of physical and mental well-being.Timepoint: 15 days

Countries

India

Contacts

Public ContactDr Shivali Arora

Guru Ravidas Ayurved University, Hoshiarpur

ps61204@gmail.com9464259162

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026